Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

46,012 stories, page 690 of 767

Advanced search

🇺🇸Apr 8Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

More about the Phase 2a Study of Baxdrostat in Primary Aldosteronism

PubMed NEJM RSSOriginal source

🇺🇸Apr 8Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

CD19 CAR T-Cell Therapy for Autoimmune Hemolytic Anemia. Reply

PubMed NEJM RSSOriginal source

🇺🇸Apr 8Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

CD19 CAR T-Cell Therapy for Autoimmune Hemolytic Anemia

PubMed NEJM RSSOriginal source

🇺🇸Apr 8Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

High-Dose Influenza Vaccine and Hospitalizations in Older Adults. Reply

PubMed NEJM RSSOriginal source

🇺🇸Apr 8Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

Trends in Youth-Onset Type 2 Diabetes, 2013-2024

PubMed NEJM RSSOriginal source

🇺🇸Apr 8Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

Altering the Diet to Rewire Cancer

PubMed NEJM RSSOriginal source

🇺🇸Apr 8Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

Case 10-2026: A 70-Year-Old Woman with a Racing Heart, Fatigue, and Dyspnea

PubMed NEJM RSSOriginal source

🇺🇸Apr 8Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

Necrolytic Migratory Erythema

PubMed NEJM RSSOriginal source

🇺🇸Apr 8Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

Celiac Disease

PubMed NEJM RSSOriginal source

🇺🇸Apr 8Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

Erratum for the Research Article "Extracellular vesicle-mediated gene editing for the treatment of nonsyndromic progressive hearing loss in adult mice"

PubMed Science Translational Medicine RSSOriginal source

🇺🇸Apr 8Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

Design of a neutralizing and protective pan-encephalitic alphavirus receptor decoy protein

PubMed Science Translational Medicine RSSOriginal source

🇺🇸Apr 8Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

Real-time intraocular pressure monitoring and responsive drug release in preclinical models by an all-polymer smart contact lens

PubMed Science Translational Medicine RSSOriginal source

🇺🇸Apr 8Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

Keratin 16 inhibits type I interferon responses in differentiating keratinocytes of stressed and diseased skin

PubMed Science Translational Medicine RSSOriginal source

🇺🇸Apr 8Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

A human iPSC model of tauopathies engineered for 4R tau isoform expression endogenously develops late-stage neuronal tau pathology

PubMed Science Translational Medicine RSSOriginal source

🇺🇸Apr 8Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

Pharmacological activation of WASp potentiates macrophage phagocytosis and enhances ibrutinib efficacy against mouse models of brain tumors

PubMed Science Translational Medicine RSSOriginal source

🇺🇸Apr 8Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

Corticosteroid resistance is predetermined by early immune response dynamics at acute graft-versus-host disease onset

PubMed Science Translational Medicine RSSOriginal source

🇺🇸Apr 8Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

Phase 1/1b study of BCMA-targeting bispecific T-cell engager pavurutamab in relapsed/refractory multiple myeloma

PubMed Blood RSSOriginal source

🇺🇸Apr 8Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

Tunneling Nanotube-Mediated Filamin A Transport Mechanosensitively Programs Osteoclastogenesis in Myeloma Bone Disease

PubMed Blood RSSOriginal source

🇺🇸Apr 8Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

A tumor suppressor role of the miR-15b/16-2 cluster in T-cell acute lymphoblastic leukemia

PubMed Blood RSSOriginal source

🌍Apr 8Devicesnamsa.comTier 1 · Company source

The Ultimate Guide to New USP Bioburden Standards: Navigating Compliance & Market Success in 2026

NAMSA RSSOriginal source

🇺🇰Apr 8Researchroyalmarsden.nhs.ukTier 2 · Direct publisher

Digital upgrade to histopathology service reduces wait time for cancer diagnosis

State-of-the-art scanners and advanced image management software allow for more efficient service.

The Royal Marsden NHS Foundation TrustOriginal source

🇸🇪Apr 8CDMOrecipharm.comTier 2 · Direct publisher

Recipharm reports strong 2025 sustainability performance, advancing industry leadership

Recipharm PressOriginal source

🇯🇵Apr 8Industryshionogi.comTier 1 · Company source

ESCMID Global 2026: Shionogi presents new real-world data highlighting clinical effectiveness of Fetroja®/Fetcroja® (cefiderocol) in MBL-producing Enterobacterales infections

・Real world evidence study carried out in Spain demonstrates 68% clinical cure rate at day 14, and 8...

ShionogiOriginal source

🇸🇦Apr 8Regulatorysfda.gov.saTier 1 · Regulatory source

SFDA and Saudi Innovation Club Sign MoU to Advance Digital Transformation and Innovation

The Saudi Food and Drug Authority (SFDA) has signed a Memorandum of Understanding (MoU) with the Sau...

SFDA (Saudi Arabia)Original source

🌍Apr 8Regulatoryispor.orgTier 1 · Regulatory source

ISPOR 2026 Plenaries and Speakers Announced

ISPOR (Professional Society for Health Economics)Original source

🇺🇸Apr 8Researchcedars-sinai.orgTier 2 · Direct publisher

Some Common IBS Treatments Linked to Higher Risk of DeathApril08,2026 02:00 AMAmerica/Los_AngelesA large, long-term study led byCedars-Sinai Health Sciences…Read more

A study from Cedars-Sinai finds long-term use of antidepressants and some antidiarrheal medications...

Cedars-Sinai Medical CenterOriginal source

🇺🇸Apr 8Industryinvestors.urogen.comTier 3 · Secondary coverage

UroGen Launches LG-UTUC Luminaries Initiative Recognizing Excellence and Leadership in Treatment of Patients with Low-Grade Upper Tract Urothelial Cancer

UroGen PharmaOriginal source

🇺🇸Apr 8Regulatoryfda.govTier 1 · Regulatory source

What’s New for Biologics

Latest news from the Center for Biologics Evaluation and Research

FDA CBER (Biologics)Original source

🇺🇸Apr 8Regulatoryfda.govTier 1 · Regulatory source

eSubmitter Application History

History of all updates to the application software in reverse chronological order by version number

FDA CBER (Biologics)Original source

🇺🇸Apr 8Regulatoryfda.govTier 1 · Regulatory source

Clinical Investigator Inspection List E-K

Contains names, addresses, and other information gathered from inspections of clinical investigators...

FDA CBER (Biologics)Original source

🇺🇸Apr 8Regulatoryfda.govTier 1 · Regulatory source

Clinical Investigator Status (Biologics)

Clinical Investigator Inspection List from inspections of clinical investigators who have conducted...

FDA CBER (Biologics)Original source

🌍Apr 8CROcrucialdatasolutions.comTier 2 · Direct publisher

Crucial Data Solutions Expands TrialKit AI with Study Simulation and Validation Capabilities

TrialKitOriginal source

🇫🇷Apr 7Industrytransgene.comTier 1 · Company source

Transgene to Participate in Upcoming Investor Meetings

TransgeneOriginal source

🇺🇸Apr 7Regulatoryfda.govTier 1 · Regulatory source

Remarks by FDA Chief Scientist Denise Hinton to the Professional Services Council FedHealth Conference - 03/11/2021

Remarks by FDA Chief Scientist Denise Hinton to the Professional Services Council FedHealth Conferen...

FDA CBER (Biologics)Original source

🌍Apr 7Industrycormedix.comTier 1 · Company source

CORMEDIX TO PARTICPATE IN NEEDHAM VIRTUAL HEALTHCARE CONFERENCE

CorMedixOriginal source

🇺🇰Apr 7CDMOergomedgroup.comTier 2 · Direct publisher

Ergomed Group Announces Board Chair Transition

ErgomedOriginal source

🇺🇸Apr 7Devicespathai.comTier 1 · Company source

PathAI and MedStar Health Announce Partnership to Deploy the AISight® Dx Digital Pathology Platform and Advanced AI Applications

PathAIOriginal source

🇪🇸Apr 7Regulatoryasebio.comTier 1 · Regulatory source

Natac’s CEO presents SustaiNext as an example of industrial scale-up at the CBE JU Stakeholder Forum 202607/04/2026Industrial biotechnologyAntonio Delgado participated in the panel “From lab to fab: enabling scale up of bio-based…Partners - Natac Group

Antonio Delgado participated in the panel “From lab to fab: enabling scale up of bio-based innovatio...

Asebio SpainOriginal source

🌍Apr 7Industrynervgen.comTier 1 · Company source

NervGen Pharma Announces Successful End-of-Phase 2 Meeting and FDA Alignment on RESTORE, a Phase 3 Registrational Study of NVG-291 for Chronic Tetraplegia

NervGen PharmaOriginal source

🌍Apr 7CROtrinetx.comTier 2 · Direct publisher

TriNetX Enhances its Ability to Federate Genomics Data Across its Global Network of Providers through the Acquisition of Key Assets of Zetta Genomics

TriNetXOriginal source

🇺🇰Apr 7Researchuclh.nhs.ukTier 2 · Direct publisher

Good luck #teamUCLH in the London Landmarks Half Marathon

University College London Hospitals (UCLH)Original source

🇺🇰Apr 7Researchuclh.nhs.ukTier 2 · Direct publisher

COVID-19 spring booster available for eligible groups

University College London Hospitals (UCLH)Original source

🇺🇸Apr 7Industryir.skyebioscience.comTier 3 · Secondary coverage

Skye Bioscience Presenting at GLP-1-Based Therapeutics Summit

SAN DIEGO, April 07, 2026 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”) a clinic...

Skye BioscienceOriginal source

🌍Apr 7Industryalloytx.comTier 1 · Company source

Alloy Therapeutics Enters into Multi-Target Collaboration and License Agreement with Biogen for Use of Alloy’s AntiClastic™ ASO Platform

Alloy TherapeuticsOriginal source

🇺🇸Apr 7Deviceswestpharma.comTier 1 · Company source

USP Revisions: What They Mean for Injectable Drug Quality and Why Packaging Matters More Than Ever

USP updates on particulate matter standards clarify subvisible particle testing requirements and the...

West Pharmaceutical ServicesOriginal source

🇫🇷Apr 7Industrysanofi.comTier 1 · Company source

Read the Press Release

Sanofi’s lunsekimig met primary and key secondary endpoints in phase 2 respiratory studies in asthma...

Sanofi NewsOriginal source

🇺🇰Apr 7Industryprnewswire.comTier 3 · Secondary coverage

TuHURA Biosciences, Inc.

IndiviorOriginal source

🇺🇰Apr 7Industryprnewswire.comTier 3 · Secondary coverage

tuhura biosciences appoints amanda garofalo mshs as senior vice president of clinical operations 302735470

IndiviorOriginal source

🇳🇱Apr 7Industrypharming.comTier 1 · Company source

Pharming Group to participate in April investor conferencesConference attendanceApril 7 2026Pharming Group N.V. today announced that its management will participate in the following investor conferences in the month of April:Read more

Pharming GroupOriginal source

🇫🇮Apr 7Industryorionpharma.comTier 1 · Company source

Pharmacists at Orion – The many paths a pharmacy degree can open up in the pharmaceutical industry4/7/2026 We are Orion Pharma

Pharmacy-trained professionals are in high demand across the pharmaceutical industry – from supply c...

Orion CorporationOriginal source

🌍Apr 7Regulatoryispor.orgTier 1 · Regulatory source

ISPOR Publishes Recommendations on Valuing Child and Adolescent Health for Economic Evaluations

ISPOR (Professional Society for Health Economics)Original source

🇺🇸Apr 7Industrygilead.comTier 1 · Company source

Gilead to Acquire Tubulis Adding Potentially Best-in-Class Antibody-Drug Conjugate and Next Generation Platform to Further Strengthen Oncology Pipeline

Gilead Sciences (Global)Original source

🇺🇸Apr 7Researchcedars-sinai.orgTier 2 · Direct publisher

The Analytical Scientist: Vibe Coding Comes to Omics

Jesse Meyer, PhD, told The Analytical Scientist how he used AI-powered vibe coding to build in minut...

Cedars-Sinai Medical CenterOriginal source

🇨🇦Apr 7Regulatorybiotech.caTier 1 · Regulatory source

Member Press Releases Apr 07, 2026Variational AI – Releases Enki 4: Major Update to Foundation Model for Small-Molecule Drug DiscoveryRead More

Variational AI introduces Enki™ 4: an improved algorithm and architecture designed to scale, expandi...

BIOTECanadaOriginal source

🇺🇸Apr 7Researchit.rutgers.eduTier 2 · Direct publisher

Spot the phish in less than five minutes

You can learn to spot phishing attempts in less than five minutes. Check out these two videos from L...

Rutgers UniversityOriginal source

🌍Apr 7Regulatoryispe.orgTier 1 · Regulatory source

Cell & Gene Covers the “Challenges with Implementing Annex 1 at the Global Level” Session from the 2026 ISPE Aseptic Conference

During the 2026 ISPE Aseptic Conference, Franck Bure, Principal Quality Technical Manager, Genentech...

ISPE (International Society for Pharmaceutical Engineering)Original source

🇺🇸Apr 7Industryinvestors.nuvalent.comTier 1 · Company source

Nuvalent Announces Submission of New Drug Application to FDA for Neladalkib in TKI Pre-treated Advanced ALK-positive NSCLC

New Drug Application (NDA) based on data in TKI pre-treated patients from the global ALKOVE-1 Phase...

NuvalentOriginal source

🇺🇸Apr 7Industryacadia.comTier 1 · Company source

acadia pharmaceuticals announces daybue stix trofinetide is now broadly available in the united states for the treatment of rett syndrome

DAYBUE STIX is a new powder formulation of trofinetide - Recently published expert consensus recogni...

Acadia PharmaceuticalsOriginal source

🌍Apr 6Industryorthofix.comTier 1 · Company source

The New AccelStim: Advanced Features, Same Proven Results

OrthofixOriginal source

🇺🇰Apr 6Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

Cancer, climate change, fossil fuels, and war: a call for action

PubMed Lancet RSSOriginal source